These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4186969)

  • 1. Glucose-6-phosphate-dehydrogenase deficiency in leprosy.
    Pettit JH; Chin J
    Lancet; 1969 Nov; 2(7628):1014. PubMed ID: 4186969
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose-6-phosphate-dehydrogenase deficiency in leprosy.
    Kher M; Grover S
    Lancet; 1969 Jun; 1(7609):1318-9. PubMed ID: 4182209
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of leprosy.
    Kulkarni AG
    Natl Med J India; 1992; 5(2):96. PubMed ID: 1304277
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
    Mysore V; al-Suwaid AR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemolytic effects of DDS in leprosy patients.
    Khaire DS; Magar NG
    Indian J Med Res; 1972 Oct; 60(10):1510-9. PubMed ID: 4661662
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of erythrocyte G6PD deficiency in leprosy.
    Banait PP; Junnarkar RV
    Int J Lepr Other Mycobact Dis; 1971; 39(2):168-71. PubMed ID: 5167841
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of ABO blood groups, G6PD deficiency, and abnormal haemoglobins in leprosy.
    Saha N; Wong HB; Banerjee B; Wong MO
    J Med Genet; 1971 Sep; 8(3):315-6. PubMed ID: 5097139
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled study of polymorphisms in serum globulin and glucose-6-phosphate dehydrogenase deficiency in leprosy.
    Lechat MF; Bias WB; Blumberg BS; Melartin L; Guinto RS; Cohen BH; Tolentino JG; Abalos RM
    Int J Lepr Other Mycobact Dis; 1968; 36(2):179-91. PubMed ID: 5691830
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glucose-6-phosphate dehydrogenase in patients with Hansen's disease receiving sulfones or sulfamethoxypyridazine].
    Takizawa H; Kobayashi S; Miura M; Fukuda M
    Nihon Rai Gakkai Zasshi; 1982; 51(2):65-7. PubMed ID: 7169392
    [No Abstract]   [Full Text] [Related]  

  • 10. The etiology of erythema nodosum leprosum.
    Pettit JH; Waters MF
    Int J Lepr Other Mycobact Dis; 1967; 35(1):1-10. PubMed ID: 6067035
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glucose-6-phosphate dehydrogenase deficiency and leprosy].
    Languillon J; Linhard J; Diebolt G
    Bull Soc Med Afr Noire Lang Fr; 1972; 17(1):132-4. PubMed ID: 5069661
    [No Abstract]   [Full Text] [Related]  

  • 12. Priapism and glucose-6-phosphate dehydrogenase deficiency: An underestimated correlation?
    De Rose AF; Mantica G; Tosi M; Bovio G; Terrone C
    Arch Ital Urol Androl; 2016 Oct; 88(3):235-236. PubMed ID: 27711102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid therapy and leprosy.
    Ramu G
    Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589
    [No Abstract]   [Full Text] [Related]  

  • 14. [Late evolutive recurrences of formerly treated leprosy].
    Merklen FP; Cottenot F; Pennec J; Blanchet P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):459-61. PubMed ID: 5170176
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythrocyte glucose-6-phosphate dehydrogenase isoenzyme phenotypes in leprosy.
    Saoji AM; Kelkar SS
    Int J Lepr Other Mycobact Dis; 1983 Mar; 51(1):41-4. PubMed ID: 6683258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ENL in borderline leprosy.
    Karat AB; Job CK; Karat S
    Int J Lepr Other Mycobact Dis; 1967; 35(3):402-3. PubMed ID: 5630364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of patients with temporomandibular joint pathology developing in lepromatous leprosy].
    Sviridov BG; Robustova TG
    Stomatologiia (Mosk); 1987; 66(3):41-3. PubMed ID: 3475833
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transition of leprous occular changes under chemotherapy].
    Arai M
    Keisei Geka; 1967 Apr; 10(2):Suppl:7-9. PubMed ID: 6070441
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quadriplegia, in lepromatous leprosy previously cleared-up, diffuse polyneuritis which appeared in spite of 6 years of follow-up consolidating treatment with Sultirene alone].
    Merklen FP; Cottenot F; Pennec J; Vernant JC; Buzacoux J
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):461-2. PubMed ID: 5150887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.